PPCB
Propanc Biopharma, Inc.
Price Chart
Latest Quote
$1.47
-0.24 (-14.04%)
Current Price
| Previous Close | $1.71 |
| Open | $1.66 |
| Day High | $1.68 |
| Day Low | $1.41 |
| Volume | 244,079 |
Stock Information
| Shares Outstanding | 2.28M |
| Total Debt | $574K |
| Cash Equivalents | $444K |
| Net Income | $-19.29M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $3.35M |
| P/E Ratio | 0.00 |
| EPS (TTM) | $572.45 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.48M |
| Income | $-19.29M |
| Book/sh | $11.24 |
| Cash/sh | $0.19 |
| Employees | 1 |
Financial Ratios
| Quick Ratio | 0.13 |
| Current Ratio | 2.37 |
| Debt/Eq | 5.30 |
Returns & Margins
| ROA | -62.31% |
| ROE | -126.98% |
Ownership
| Insider Ownership | 14.85% |
| Institutional Ownership | 0.81% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | 0.13 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $1.74 |
| SMA50 | $2.18 |
| SMA200 | $16.34 |
| RSI | 43.22 |
| ATR | 0.6512 |
| Shares Float | 1.63M |
| Short Float | 1.53% |
| Short Ratio | 0.51 |
| Rel Volume | 0.03 |
Performance History
| Week | -39.51% |
| Month | -26.68% |
| Quarter | -49.74% |
| 6 Months | -91.96% |
| YTD | -89.71% |
| Year | -98.85% |
| 3 Years | -41.20% |
| 5 Years | -99.95% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $1.47 | 244,100 |
| 2026-06-17 | $1.71 | 217,500 |
| 2026-06-16 | $1.93 | 732,000 |
| 2026-06-15 | $2.15 | 814,700 |
| 2026-06-12 | $2.27 | 1,855,300 |
| 2026-06-11 | $2.43 | 174,627,200 |
| 2026-06-10 | $1.35 | 20,900 |
| 2026-06-09 | $1.38 | 34,400 |
| 2026-06-08 | $1.37 | 29,000 |
| 2026-06-05 | $1.45 | 26,400 |
| 2026-06-04 | $1.66 | 31,400 |
| 2026-06-03 | $1.63 | 14,900 |
| 2026-06-02 | $1.77 | 15,500 |
| 2026-06-01 | $1.81 | 25,600 |
| 2026-05-29 | $1.82 | 68,400 |
| 2026-05-28 | $1.70 | 11,800 |
| 2026-05-27 | $1.62 | 37,300 |
| 2026-05-26 | $1.74 | 91,000 |
| 2026-05-22 | $1.76 | 55,300 |
| 2026-05-21 | $1.73 | 25,500 |
| 2026-05-20 | $1.76 | 69,000 |
| 2026-05-19 | $2.01 | 167,000 |
| 2026-05-18 | $nan | 0 |
About Propanc Biopharma, Inc.
Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research and collaboration agreement with the University of JaÊn, to undertakes the research activities for the POP1 Program and the University of Granada to develop a synthetic recombinant version of PRP. Propanc Biopharma, Inc. was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. The company was incorporated in 2007 and is based in Camberwell, Australia.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $563,757 | $665,841 | $532,821 | $568,798 |
| Total Expenses | $57,278,131 | $1,536,049 | $1,776,645 | $1,990,870 |
| Rent Expense Supplemental | $26,560 | $34,150 | $28,841 | $28,366 |
| Other Income Expense | $-1,081,421 | $252,170 | $-480,977 | $-159,009 |
| Net Non Operating Interest Income Expense | $-563,748 | $-665,781 | $-532,785 | $-563,185 |
| Interest Expense Non Operating | $563,757 | $665,841 | $532,821 | $568,798 |
| Operating Expense | $57,278,131 | $1,536,049 | $1,776,645 | $1,990,870 |
| General And Administrative Expense | $57,054,410 | $1,287,947 | $1,528,726 | $1,734,818 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-58,923,300 | $-1,820,528 | $-2,660,566 | $-2,658,087 |
| Net Interest Income | $-563,748 | $-665,781 | $-532,785 | $-563,185 |
| Interest Income | $9 | $60 | $36 | $5,613 |
| Normalized Income | $-57,841,879 | $-2,072,698 | $-2,201,969 | $-2,502,300 |
| Net Income From Continuing And Discontinued Operation | $-58,923,300 | $-1,820,528 | $-2,660,566 | $-2,658,087 |
| Total Operating Income As Reported | $-57,278,131 | $-1,536,049 | $-1,776,645 | $-1,990,870 |
| Net Income Common Stockholders | $-58,923,300 | $-2,013,488 | $-3,126,839 | $-3,358,427 |
| Net Income | $-58,923,300 | $-1,820,528 | $-2,660,566 | $-2,658,087 |
| Net Income Including Noncontrolling Interests | $-58,923,300 | $-1,820,528 | $-2,660,566 | $-2,658,087 |
| Net Income Continuous Operations | $-58,923,300 | $-1,820,528 | $-2,660,566 | $-2,658,087 |
| Pretax Income | $-58,923,300 | $-1,949,660 | $-2,790,407 | $-2,713,064 |
| Special Income Charges | $-871,032 | $54,565 | $43,468 | $-17,503 |
| Interest Income Non Operating | $9 | $60 | $36 | $5,613 |
| Operating Income | $-57,278,131 | $-1,536,049 | $-1,776,645 | $-1,990,870 |
| Per Share | ||||
| Diluted EPS | $-14.85 | $-1420.53 | $-781709.75 | $-1119475.67 |
| Basic EPS | $-14.85 | $-1420.53 | $-781709.75 | $-1119475.67 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $-22,380 | $-3,222 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-57,257,935 | $-1,514,333 | $-1,753,678 | $-1,979,586 |
| Total Unusual Items | $-1,081,421 | $252,170 | $-480,977 | $-159,009 |
| Total Unusual Items Excluding Goodwill | $-1,081,421 | $252,170 | $-480,977 | $-159,009 |
| Reconciled Depreciation | $20,187 | $21,656 | $22,931 | $5,671 |
| EBITDA (Bullshit earnings) | $-58,339,356 | $-1,262,163 | $-2,234,655 | $-2,138,595 |
| EBIT | $-58,359,543 | $-1,283,819 | $-2,257,586 | $-2,144,266 |
| Diluted Average Shares | $3,968,176 | $1,417 | $4 | $3 |
| Basic Average Shares | $3,968,176 | $1,417 | $4 | $3 |
| Diluted NI Availto Com Stockholders | $-58,923,300 | $-2,013,488 | $-3,126,839 | $-3,358,427 |
| Otherunder Preferred Stock Dividend | $0 | $192,960 | $466,273 | $700,340 |
| Tax Provision | $0 | $-129,132 | $-129,841 | $-54,977 |
| Other Special Charges | $871,032 | $-54,565 | $-43,468 | $17,503 |
| Gain On Sale Of Security | $-210,389 | $197,605 | $-524,445 | $-141,506 |
| Research And Development | $223,721 | $248,102 | $247,919 | $256,052 |
| Selling General And Administration | $57,054,410 | $1,287,947 | $1,528,726 | $1,734,818 |
| Other Gand A | $57,027,850 | $1,253,797 | $1,499,885 | $1,706,452 |
| Rent And Landing Fees | $26,560 | $34,150 | $28,841 | $28,366 |
Fetched: 2026-06-21
Balance Sheet (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $13,906,192 | $-3,779,059 | $-3,117,179 | $-3,023,649 |
| Total Assets | $19,631,808 | $72,365 | $60,328 | $81,651 |
| Total Non Current Assets | $11,278,992 | $46,924 | $41,289 | $66,621 |
| Non Current Prepaid Assets | $10,927,806 | $2,008 | $1,999 | $2,075 |
| Non Current Deferred Assets | $291,773 | $27,117 | $0 | - |
| Current Assets | $8,352,816 | $25,441 | $19,039 | $15,030 |
| Other Current Assets | $1,380 | $1,406 | $6,125 | $8,621 |
| Prepaid Assets | $8,334,046 | $0 | $6,125 | $8,621 |
| Receivables | $5,302 | $2,950 | $2,867 | $2,342 |
| Taxes Receivable | $5,302 | $2,950 | $2,867 | $2,342 |
| Cash Cash Equivalents And Short Term Investments | $12,088 | $21,085 | $10,047 | $4,067 |
| Cash And Cash Equivalents | $12,088 | $21,085 | $10,047 | $4,067 |
| Cash Financial | $12,088 | $21,085 | $10,047 | $4,067 |
| Debt | ||||
| Net Debt | $1,655,381 | $907,824 | $495,086 | $973,542 |
| Total Debt | $1,726,882 | $948,271 | $545,916 | $1,040,533 |
| Long Term Debt And Capital Lease Obligation | $147,376 | $58,642 | $19,278 | $42,319 |
| Long Term Debt | $105,627 | $58,642 | - | - |
| Current Debt And Capital Lease Obligation | $1,579,506 | $889,629 | $526,638 | $998,214 |
| Current Debt | $1,561,842 | $870,267 | $505,133 | $977,609 |
| Other Current Borrowings | $1,018,530 | $665,573 | $505,133 | $977,609 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $5,725,616 | $3,851,424 | $3,177,507 | $3,105,300 |
| Total Non Current Liabilities Net Minority Interest | $147,376 | $58,642 | $19,278 | $42,319 |
| Current Liabilities | $5,578,240 | $3,792,782 | $3,158,229 | $3,062,981 |
| Other Current Liabilities | $403,892 | $133,886 | $423,209 | $151,262 |
| Current Notes Payable | $543,312 | $204,694 | $0 | - |
| Payables And Accrued Expenses | $2,926,941 | $2,129,896 | $1,620,764 | $1,497,706 |
| Interest Payable | $190,795 | $94,612 | $44,709 | $57,822 |
| Payables | $1,249,596 | $1,243,094 | $996,348 | $973,769 |
| Accounts Payable | $1,249,596 | $1,213,335 | $966,718 | $943,023 |
| Equity | ||||
| Common Stock Equity | $13,906,192 | $-3,779,059 | $-3,117,179 | $-3,028,649 |
| Total Equity Gross Minority Interest | $13,906,192 | $-3,779,059 | $-3,117,179 | $-3,023,649 |
| Stockholders Equity | $13,906,192 | $-3,779,059 | $-3,117,179 | $-3,023,649 |
| Gains Losses Not Affecting Retained Earnings | $1,318,917 | $1,269,581 | $1,294,876 | $1,234,549 |
| Other Equity Adjustments | $1,318,917 | $1,269,581 | $1,294,876 | $1,234,549 |
| Retained Earnings | $-125,621,520 | $-66,698,220 | $-64,684,732 | $-61,557,893 |
| Preferred Stock Equity | - | - | - | $5,000 |
| Other Equity Interest | - | - | - | $-23,758 |
| Other | ||||
| Ordinary Shares Number | $464,471 | $319 | $4 | $0 |
| Share Issued | $464,471 | $319 | $4 | $3 |
| Tangible Book Value | $13,906,192 | $-3,779,059 | $-3,117,179 | $-3,028,649 |
| Invested Capital | $15,573,661 | $-2,850,150 | $-2,612,046 | $-2,051,040 |
| Working Capital | $2,774,576 | $-3,767,341 | $-3,139,190 | $-3,047,951 |
| Capital Lease Obligations | $59,413 | $19,362 | $40,783 | $62,924 |
| Total Capitalization | $14,011,819 | $-3,720,417 | $-3,117,179 | $-3,023,649 |
| Treasury Stock | $46,477 | $46,477 | $46,477 | $46,477 |
| Additional Paid In Capital | $138,243,652 | $61,696,049 | $60,311,502 | $57,364,690 |
| Capital Stock | $11,620 | $8 | $7,652 | $5,240 |
| Common Stock | $11,620 | $8 | $7,652 | $240 |
| Preferred Stock | $0 | $0 | $0 | $5,000 |
| Long Term Capital Lease Obligation | $41,749 | $0 | $19,278 | $42,319 |
| Current Capital Lease Obligation | $17,664 | $19,362 | $21,505 | $20,605 |
| Pensionand Other Post Retirement Benefit Plans Current | $667,901 | $639,371 | $587,618 | $415,799 |
| Current Accrued Expenses | $1,677,345 | $886,802 | $624,416 | $523,937 |
| Dueto Related Parties Current | $0 | $29,759 | $29,630 | $30,746 |
| Net PPE | $59,413 | $17,799 | $39,290 | $64,546 |
| Accumulated Depreciation | $-93,992 | $-73,945 | $-52,343 | $-30,278 |
| Gross PPE | $153,405 | $91,744 | $91,633 | $94,824 |
| Machinery Furniture Equipment | $25,078 | $25,543 | $25,432 | $28,623 |
| Buildings And Improvements | $128,327 | $66,201 | $66,201 | $66,201 |
| Properties | $0 | $0 | $0 | $0 |
| Treasury Shares Number | - | $0 | $0 | $0 |
| Preferred Shares Number | - | - | - | $500,001 |
Fetched: 2026-06-21
Cash Flow Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-405,168 | $-935,118 | $-1,105,251 | $-1,436,304 |
| Operating Activities | ||||
| Operating Cash Flow | $-405,168 | $-935,118 | $-1,105,251 | $-1,436,304 |
| Cash Flow From Continuing Operating Activities | $-405,168 | $-935,118 | $-1,105,251 | $-1,436,304 |
| Operating Gains Losses | $1,081,421 | $27,541 | $733,558 | $683,830 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $23,057 | $24,711 | $99,285 |
| Financing Cash Flow | $490,756 | $941,894 | $1,113,719 | $1,490,786 |
| Cash Flow From Continuing Financing Activities | $490,756 | $941,894 | $1,113,719 | $1,490,786 |
| Net Other Financing Charges | $-264,656 | - | $23,758 | - |
| Net Common Stock Issuance | $0 | $23,057 | $24,711 | $99,285 |
| Common Stock Issuance | $0 | $23,057 | $24,711 | $99,285 |
| Other | ||||
| Repayment Of Debt | $-130,788 | $-142,909 | $0 | $0 |
| Issuance Of Debt | $886,200 | $1,061,746 | $590,250 | $766,500 |
| Interest Paid Supplemental Data | $30,715 | $9,491 | $2,883 | $2,392 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $12,088 | $21,085 | $10,047 | $4,067 |
| Beginning Cash Position | $21,085 | $10,047 | $4,067 | $2,255 |
| Effect Of Exchange Rate Changes | $-94,585 | $4,262 | $-2,488 | $-52,670 |
| Changes In Cash | $85,588 | $6,776 | $8,468 | $54,482 |
| Net Issuance Payments Of Debt | $755,412 | $918,837 | $590,250 | $766,500 |
| Net Short Term Debt Issuance | $411,712 | $614,141 | $590,250 | $766,500 |
| Short Term Debt Payments | $-130,788 | $-142,909 | $0 | - |
| Short Term Debt Issuance | $542,500 | $757,050 | $590,250 | $766,500 |
| Net Long Term Debt Issuance | $343,700 | $304,696 | $0 | $766,500 |
| Long Term Debt Issuance | $343,700 | $304,696 | $0 | $766,500 |
| Change In Working Capital | $1,138,212 | $417,418 | $472,587 | $167,435 |
| Change In Other Working Capital | $40,184 | $24,196 | $186,912 | $29,907 |
| Change In Other Current Liabilities | $-21,722 | $-21,598 | $-19,857 | $-3,277 |
| Change In Payables And Accrued Expense | $1,120,776 | $531,103 | $303,960 | $147,765 |
| Change In Accrued Expense | $933,044 | $288,695 | $222,985 | $128,895 |
| Change In Interest Payable | $255,155 | $78,733 | $92,474 | $63,878 |
| Change In Payable | $187,732 | $242,408 | $80,975 | $18,870 |
| Change In Account Payable | $187,732 | $242,408 | $80,975 | $18,870 |
| Change In Prepaid Assets | $1,379 | $-116,212 | $2,182 | $-8,620 |
| Change In Receivables | $-2,405 | $-71 | $-610 | $1,660 |
| Other Non Cash Items | $51,657,082 | $297,837 | $326,239 | $364,847 |
| Stock Based Compensation | $4,621,230 | $0 | - | - |
| Provisionand Write Offof Assets | $0 | $120,958 | $0 | - |
| Depreciation Amortization Depletion | $20,187 | $21,656 | $22,931 | $5,671 |
| Depreciation And Amortization | $20,187 | $21,656 | $22,931 | $5,671 |
| Depreciation | $20,187 | $21,656 | $22,931 | $5,671 |
| Gain Loss On Investment Securities | $121,146 | $104,186 | $765,412 | $623,932 |
| Net Foreign Currency Exchange Gain Loss | $89,243 | $-22,080 | $-5,885 | $42,395 |
| Net Income From Continuing Operations | $-58,923,300 | $-1,820,528 | $-2,660,566 | $-2,658,087 |
| Proceeds From Stock Option Exercised | - | $0 | $475,000 | $625,001 |
| Long Term Debt Payments | - | - | - | $0 |
| Amortization Of Securities | - | - | - | $452,308 |
Fetched: 2026-06-21